BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-08 5:00 pm Purchase |
2021-07-06 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 372,617 10.100% |
154,555 (+70.88%) |
Filing |
| 2021-02-11 5:25 pm Sale |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 218,062 6.200% |
-136,470 (-38.49%) |
Filing |
| 2020-05-26 4:56 pm Sale |
2020-05-21 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 354,532 10.100% |
-123,450 (-25.83%) |
Filing |